A RANDOMIZED, CONTROLLED, MULTICENTER TRIAL OF FILGRASTIM (RECOMBINANT-METHIONYL HUMAN GRANULOCYTE COLONY STIMULATING FACTOR; G-CSF) FOR THE PREVENTION OF GRADE 4 NEUTROPENIA IN PATIENTS WITH HIV INFECTION.: